Effect of Hydrocortisone on Mortality and Organ Support in patients with Severe COVID-19
Among patients with severe COVID-19, treatment with a 7-day fixed-dose course of hydrocortisone or shock-dependent dosing of hydrocortisone, compared with no hydrocortisone, resulted in 93% and 80% probabilities of superiority with regard to the odds of improvement in organ support–free days within 21 days. However, the trial was stopped early and no treatment strategy met prespecified criteria for statistical superiority, precluding definitive conclusions.
A living WHO guideline on drugs for COVID-19
Updates This is the ninth version (eighth update) of the living guideline, replacing earlier versions, available as data supplements.
